• Caterina Vicens, Isabel Socias, Catalina Mateu, Alfonso Leiva, Ferran Bejarano, Ermengol Sempere, Josep Basora, Vicente Palop, Marta Mengual, Jose Luis Beltran, Enric Aragonès, Guillem Lera, Silvia Folch, Josep Lluís Piñol, Magdalena Esteva, Miguel Roca, Arturo Arenas, María Del Mar Sureda, Francisco Campoamor, and Francisca Fiol.
• Son Serra- La Vileta Health Care Centre, Balearic Mental Health Research Group, Balearic Health service-IbSalut, Mallorca, Spain. cvicenscaldentey@ibsalut.caib.es
• Bmc Fam Pract. 2011 Jan 1;12:23.

BackgroundAlthough benzodiazepines are effective, long-term use is not recommended because of potential adverse effects; the risks of tolerance and dependence; and an increased risk of hip fractures, motor vehicle accidents, and memory impairment. The estimated prevalence of long-term benzodiazepine use in the general population is about 2,2 to 2,6%, is higher in women and increases steadily with age. Interventions performed by General Practitioners may help patients to discontinue long-term benzodiazepine use. We have designed a trial to evaluate the effectiveness and safety of two brief general practitioner-provided interventions, based on gradual dose reduction, and will compare the effectiveness of these interventions with that of routine clinical practice.Methods/DesignIn a three-arm cluster randomized controlled trial, general practitioners will be randomly allocated to: a) a group in which the first patient visit will feature a structured interview, followed by visits every 2-3 weeks to the end of dose reduction; b) a group in which the first patient visit will feature a structured interview plus delivery of written instructions to self-reduce benzodiazepine dose, or c) routine care. Using a computerized pharmaceutical prescription database, 495 patients, aged 18-80 years, taking benzodiazepine for at least 6 months, will be recruited in primary care health districts of three regions of Spain (the Balearic Islands, Catalonia, and Valencia). The primary outcome will be benzodiazepine use at 12 months. The secondary outcomes will include measurements of anxiety and depression symptoms, benzodiazepine dependence, quality of sleep, and alcohol consumption.DiscussionAlthough some interventions have been shown to be effective in reducing benzodiazepine consumption by long-term users, the clinical relevance of such interventions is limited by their complexity. This randomized trial will compare the effectiveness and safety of two complex stepped care interventions with that of routine care in a study with sufficient statistical power to detect clinically relevant differences.Trial RegistrationCurrent Controlled Trials: ISRCTN13024375.

23 keywords...

hide…